CRA’s Forensic Services professionals were retained by Jones Walker to assist its client, a genetic testing lab, respond to False Claims Act whistleblower allegations that it had furnished and billed federal payers for tests that were not medically necessary. We reviewed a sample population of charts for subjects who had been enrolled in clinical trials and assessed their eligibility for inclusion. Our findings allowed the client to mount a vigorous defense and achieve a favorable outcome.
DOJ declinations show the value of early voluntary disclosure
US Department of Justice (DOJ) declinations involving Robert Bosch GmbH (Bosch) and Campus Eye Management Holdings LLC (Campus Eye) offer early insight into...

